Around 175,000 New Zealanders live with heart failure. It is another of those conditions that become more likely as we age and, although there is no cure, it can be managed with a range of medications.
Heart failure doesn't mean the heart has actually failed or stopped, but that pumping enough blood around the body has become harder. This may be because the heart muscle has stretched and weakened, or it may have thickened and stiffened, or been irreversibly damaged by a heart attack. Either way, sufferers experience fluid build-up leading to a range of symptoms such as shortness of breath, extreme fatigue and swelling in the legs and feet. More than half of people diagnosed with heart failure will survive for five years and about 35% survive for 10 years.
Now, researchers at the University of Auckland are trialling a drug they believe has the potential to not only improve the heart's ability to pump, but also reverse the progression of heart failure.
"This is a completely new class of drug with a different mechanism," says Julian Paton, director of the university's Manaaki Manawa Centre for Heart Research. "What it does, that the others do not, is reduce autonomic nervous system activation to the heart."
Known as AF-130, the drug was first developed as a medication for unexplained chronic cough, a common and hard-to-treat ailment. It is a P2x3 receptor blocker and it seems to have multiple other uses. P2x3 receptors are channels that let sodium and calcium ions into the cells, which create electrical excitability and are key to communication with the brain. The chemical that stimulates these receptors is called ATP (adenosine triphosphate) and it is essential for many cellular processes.
"ATP is doing a lot in the body," says Paton. "But what caught our attention is that in disease, it does too much."
Bu hikaye New Zealand Listener dergisinin April 29- May 05, 2023 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye New Zealand Listener dergisinin April 29- May 05, 2023 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
First-world problem
Harrowing tales of migrants attempting to enter the US highlight the political failure to fully tackle the problem.
Applying intelligence to AI
I call it the 'Terminator Effect', based on the premise that thinking machines took over the world.
Nazism rears its head
Smirky Höcke, with his penchant for waving with a suspiciously straight elbow and an open palm, won't get to be boss of either state.
Staying ahead of the game
Will the brave new world of bipartisanship that seems to be on offer with an Infrastructure Commission come to fruition?
Grasping the nettle
Broccoli is horrible. It smells, when being cooked, like cat pee.
Hangry? Eat breakfast
People who don't break their fast first thing in the morning report the least life satisfaction.
Chemical reaction
Nitrates in processed meats are well known to cause harm, but consumed from plant sources, their effect is quite different.
Me and my guitar
Australian guitarist Karin Schaupp sticks to the familiar for her Dunedin concerts.
Time is on my side
Age does not weary some of our much-loved musicians but what keeps them on the road?
The kids are not alright
Nuanced account details how China's blessed generation has been replaced by one consumed by fear and hopelessness.